ATE392437T1 - Anti-idiotypische antikörper gegen antikörper, welche die bindung zwischen immunoglobulin e und seinem hochaffinitätsrezeptor hemmen - Google Patents

Anti-idiotypische antikörper gegen antikörper, welche die bindung zwischen immunoglobulin e und seinem hochaffinitätsrezeptor hemmen

Info

Publication number
ATE392437T1
ATE392437T1 AT00918868T AT00918868T ATE392437T1 AT E392437 T1 ATE392437 T1 AT E392437T1 AT 00918868 T AT00918868 T AT 00918868T AT 00918868 T AT00918868 T AT 00918868T AT E392437 T1 ATE392437 T1 AT E392437T1
Authority
AT
Austria
Prior art keywords
immunoglobulin
inhibit
binding
affinity receptor
antibodies
Prior art date
Application number
AT00918868T
Other languages
English (en)
Inventor
Franz Kricek
Beda Stadler
Monique Vogel
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE392437T1 publication Critical patent/ATE392437T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00918868T 1999-04-14 2000-04-12 Anti-idiotypische antikörper gegen antikörper, welche die bindung zwischen immunoglobulin e und seinem hochaffinitätsrezeptor hemmen ATE392437T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9908533.4A GB9908533D0 (en) 1999-04-14 1999-04-14 Organic compounds

Publications (1)

Publication Number Publication Date
ATE392437T1 true ATE392437T1 (de) 2008-05-15

Family

ID=10851525

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00918868T ATE392437T1 (de) 1999-04-14 2000-04-12 Anti-idiotypische antikörper gegen antikörper, welche die bindung zwischen immunoglobulin e und seinem hochaffinitätsrezeptor hemmen

Country Status (29)

Country Link
US (1) US7041288B2 (de)
EP (1) EP1169353B1 (de)
JP (1) JP4109829B2 (de)
KR (1) KR100492202B1 (de)
CN (1) CN1268644C (de)
AR (1) AR029624A1 (de)
AT (1) ATE392437T1 (de)
AU (1) AU767712B2 (de)
BR (1) BR0009781A (de)
CA (1) CA2363991C (de)
CO (1) CO5241329A1 (de)
CZ (1) CZ20013673A3 (de)
DE (1) DE60038608T2 (de)
ES (1) ES2302693T3 (de)
GB (1) GB9908533D0 (de)
HK (1) HK1044544B (de)
HU (1) HUP0200713A2 (de)
IL (2) IL145507A0 (de)
MX (1) MXPA01010348A (de)
MY (1) MY141459A (de)
NO (1) NO20014936L (de)
PE (1) PE20010046A1 (de)
PL (1) PL350676A1 (de)
PT (1) PT1169353E (de)
RU (1) RU2253655C2 (de)
SK (1) SK14592001A3 (de)
TR (1) TR200102877T2 (de)
WO (1) WO2000063252A1 (de)
ZA (1) ZA200107906B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
GB0103174D0 (en) * 2001-02-08 2001-03-28 Smithkline Beecham Plc Novel method of treatment
EP1239032A1 (de) * 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Milchsäurebakterien als Mitteln zur Behandlung und Vorbeugung von Allergie
SE0101093D0 (sv) 2001-03-28 2001-03-28 Pharmacia Diagnostics Ab Novel compound for treatment of allergy and asthma
WO2003015716A2 (en) 2001-08-13 2003-02-27 Ige Therapeutics, Inc. Immunoglobulin e vaccines and methods of use thereof
TWI323265B (en) 2002-08-06 2010-04-11 Glaxo Group Ltd Antibodies
GB0306309D0 (en) 2003-03-19 2003-04-23 Glaxo Group Ltd Method of treatment
US8029783B2 (en) * 2005-02-02 2011-10-04 Genentech, Inc. DR5 antibodies and articles of manufacture containing same
CN101062949B (zh) * 2006-04-26 2011-07-27 上海抗体药物国家工程研究中心有限公司 重组抗人IgE单克隆抗体及其制备方法和用途
US20080118524A1 (en) * 2006-10-20 2008-05-22 Stefan Persson Anti-IgE Vaccines
UA95329C2 (ru) * 2006-12-14 2011-07-25 Шеринг-Плау Лтд. Собачий тимусный стромальный лимфопоэтин и его применение
MY163512A (en) 2009-09-03 2017-09-15 Pfizer Vaccines Llc Pcsk9 vaccine
RU2595409C2 (ru) 2009-09-03 2016-08-27 Мерк Шарп И Доум Корп., Анти-gitr-антитела
US10214593B2 (en) 2013-04-02 2019-02-26 Samsung Electronics Co., Ltd. Anti-idiotype antibody against anti-c-MET antibody
KR20210133261A (ko) * 2019-02-26 2021-11-05 소렌토 쎄라퓨틱스, 인코포레이티드 Bcma에 결합하는 항원 결합 단백질

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
EP0291636A1 (de) 1983-11-07 1988-11-23 The Wistar Institute Von Anti-Idiotyp-Antikörpern induzierte Immunreaktion gegen Viren
CA1341235C (en) 1987-07-24 2001-05-22 Randy R. Robinson Modular assembly of antibody genes, antibodies prepared thereby and use
AU618317B2 (en) * 1987-12-31 1991-12-19 Tanox Biosystems, Inc. Unique antigenic epitopes on ige-bearing b lymphocytes
DE69126607T2 (de) 1990-01-23 1998-01-15 Tanox Biosystems, Inc., Houston, Tex. Extrazelluläre teilstücke humaner ige-immunoglobulin-ankerpeptide und dafür spezifische antikörper
IT1238286B (it) 1990-03-26 1993-07-12 Dispositivo sensore di livello del liquido per caldaie a vapore.
US5512283A (en) 1990-07-06 1996-04-30 Allergene, Inc. Methods for the selective suppression of an immune response to dust mite der Pi
ES2194015T3 (es) 1992-09-30 2003-11-16 Scripps Research Inst Anticuerpos monoclonales humanos neutralizantes del virus de inmunodeficiencia humana.
DE69718150T3 (de) * 1996-03-01 2009-03-05 Novartis Ag Peptid-immunogene zur schutzimpfung gegen und behandlung von allergien
JPH11174A (ja) * 1997-06-13 1999-01-06 Asahi Breweries Ltd 酵母を用いた抗体Ｆａｂ断片の製造法
US5994511A (en) 1997-07-02 1999-11-30 Genentech, Inc. Anti-IgE antibodies and methods of improving polypeptides
WO1999055911A1 (en) 1998-04-24 1999-11-04 Fang Fang Identifying peptide ligands of target proteins with target complementary library technology (tclt)

Also Published As

Publication number Publication date
HK1044544A1 (en) 2002-10-25
EP1169353B1 (de) 2008-04-16
CN1346372A (zh) 2002-04-24
ZA200107906B (en) 2003-08-27
PE20010046A1 (es) 2001-02-23
PT1169353E (pt) 2008-07-14
PL350676A1 (en) 2003-01-27
DE60038608D1 (de) 2008-05-29
CA2363991A1 (en) 2000-10-26
IL145507A (en) 2008-11-03
AU3966000A (en) 2000-11-02
CN1268644C (zh) 2006-08-09
AR029624A1 (es) 2003-07-10
WO2000063252A1 (en) 2000-10-26
DE60038608T2 (de) 2009-06-10
NO20014936D0 (no) 2001-10-10
NO20014936L (no) 2001-12-03
KR20020007366A (ko) 2002-01-26
CO5241329A1 (es) 2003-01-31
US7041288B2 (en) 2006-05-09
KR100492202B1 (ko) 2005-06-03
IL145507A0 (en) 2002-06-30
JP4109829B2 (ja) 2008-07-02
AU767712B2 (en) 2003-11-20
RU2253655C2 (ru) 2005-06-10
BR0009781A (pt) 2002-01-08
CZ20013673A3 (cs) 2002-05-15
TR200102877T2 (tr) 2002-01-21
MXPA01010348A (es) 2002-10-23
MY141459A (en) 2010-04-30
HK1044544B (zh) 2008-11-21
JP2002544125A (ja) 2002-12-24
US20020141989A1 (en) 2002-10-03
SK14592001A3 (sk) 2002-05-09
CA2363991C (en) 2010-06-08
GB9908533D0 (en) 1999-06-09
EP1169353A1 (de) 2002-01-09
HUP0200713A2 (en) 2002-07-29
ES2302693T3 (es) 2008-08-01

Similar Documents

Publication Publication Date Title
LTPA2019521I1 (lt) Rapamicino darinys, skirtas kieto naviko, susijusio su nereguliuojama angiogeneze, gydymui
ATE392437T1 (de) Anti-idiotypische antikörper gegen antikörper, welche die bindung zwischen immunoglobulin e und seinem hochaffinitätsrezeptor hemmen
DE60141855D1 (de) Antikörper gegen den rezeptor für den insulinähnlichen wachstumsfaktor i
CY2010003I2 (el) Αγωνιστες των βητα-2 αδρενεργικων υποδοχεων
DE69928030D1 (de) Gurtstraffer
DE60025241D1 (de) HäMOPOIETINREZEPTOR-PROTEIN, NR12
NO20016246L (no) Selektiv iGluR5 reseptorantagonist for behandling av migrene
NO20013997L (no) Reseptoranalyse
ID28664A (id) Raga katalis
DE50010446D1 (de) Emulsionen
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
DE60014306D1 (de) Tintenstrahlaufzeichnungselement
HK1064367A1 (en) Oxazol/thiazol-derivatives activatorsof the hppar-alpha receptor
DE60205717D1 (de) 2-arylimino-2,3-dihydrothiazol derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
DE69811651D1 (de) Enthaarungszusammensetzungen, die bereitung und die verwendung derselben
DE60017345D1 (de) Tintenstrahlaufzeichnungselement
NO20021295L (no) Nikotinsyreacetylcholin-reseptor
NO20011006D0 (no) Høy-affinitets antistoffer
NO20005773D0 (no) Pyroteknisk struktur
AR024711A1 (es) Procedimiento para la elaboracion de material de cerda de varias capas, cerda de varias capas y su empleo.
DE60014616D1 (de) Antikörper gegen plazentaprotein 13
AR027974A1 (es) 1-aril-ciclopropilmetilamino-1,3,5-triazinas substituidas
DE60005282D1 (de) Golfschlägerkopf, golfschläger und golfschlägerset
FR2794001B1 (fr) La cravate suspensoir
ES1047631Y (es) Dispositivo para la fabricacion de piezas modulares para la construccion.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1169353

Country of ref document: EP

REN Ceased due to non-payment of the annual fee